Entegrion Receives $1.9 Million from Navy for Blood Product and…
Funding applied to Phase 1 studies for ResusixTM, a spray-dried, solvent detergent-treated human plasma, and for further development of a Multi-functional Resuscitation Fluid (MRF) that provides a…(PRWeb July 31, 2012)Read the full story at http:/…
Entegrion Receives $1.9 Million from Navy for Blood Product and… Read Post »
